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Abstract
Introduction  and  Objectives:  Estimates  of  the  burden  of  ischemic  heart  disease  (IHD),  including
geographic differences,  should  support  health  policy  decisions.  We  set  out  to  estimate  the
burden of  IHD  in  mainland  Portugal  in  2013  by  calculating  disability-adjusted  life  years  (DALYs)
and to  compare  this  burden  between  ﬁve  regions.
Methods:  Years  of  life  lost  (YLLs)  were  calculated  by  multiplying  the  number  of  IHD  deaths
in 2013  (Statistics  Portugal)  by  the  life  expectancy  at  the  age  at  which  death  occurred.  Years
lived with  disability  (YLDs)  were  computed  as  the  number  of  cases  of  acute  coronary  syndrome,
stable angina  and  ischemic  heart  failure  multiplied  by  an  average  disability  weight.  Crude  and
age-standardized  DALYs  (direct  method,  Standard  European  Population)  were  calculated  for
mainland Portugal  and  for  the  Northern,  Central,  Lisbon,  Alentejo  and  Algarve  regions.
Results:  In  2013,  95  413  DALYs  were  lost  in  mainland  Portugal  due  to  IHD.  YLLs  accounted  for
88.3% of  the  disease  burden.  Age-standardized  DALY  rates  per  1000  population  were  higher  in
men than  in  women,  across  the  entire  country  (8.9  in  men;  3.4  in  women)  and  within  each
region, ranging  from  7.3  in  the  Northern  and  Central  regions  to  11.8  in  the  Algarve  in  men,  and
from 2.6  in  the  Northern  region  to  4.6  in  Lisbon  in  women.
Conclusions:  Nearly  100  000  DALYs  were  lost  to  IHD  in  Portugal,  mostly  through  early  mortality.
This study  enables  accurate  comparisons  with  other  countries  and  between  regions;  however,
it highlights  the  need  for  population-based  studies  to  obtain  speciﬁc  data  on  morbidity.
© 2017  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  All  rights
reserved.∗ Corresponding author.
E-mail address: alhenriques@med.up.pt (A. Henriques).
http://dx.doi.org/10.1016/j.repc.2016.08.011
0870-2551/© 2017 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan˜a, S.L.U. All rights reserved.
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Anos  de  vida  saudável  perdidos  devido  a  doenc¸a isquémica  do  corac¸ão em  Portugal
continental  em  2013
Resumo
Introduc¸ão  e  objetivos:  A  carga  de  doenc¸a  atribuível  à  doenc¸a  isquémica  do  corac¸ão  (DIC),
nomeadamente  possíveis  diferenc¸as  regionais,  deve  orientar  políticas  de  saúde.  Pretendemos
estimar a  carga  de  doenc¸a  atribuível  a  DIC  em  Portugal  continental  em  2013,  através  do  cálculo
dos anos  de  vida  saudável  perdidos  (DALY)  e  comparar  estas  estimativas  entre  regiões.
Métodos: Calcularam-se  os  anos  de  vida  perdidos  (YLL)  multiplicando  o  número  de  mortes  por
DIC em  2013  (Instituto  Nacional  de  Estatística)  pela  esperanc¸a  média  de  vida  à  idade  da  morte.
Estimaram-se  os  anos  vividos  com  incapacidade  (YLD)  através  do  número  de  casos  de  síndrome
coronária  aguda,  angina  estável  e  insuﬁciência  cardíaca  isquémica.  Os  DALY  brutos  e  padroniza-
dos para  a  idade  (método  direto,  populac¸ão-padrão  europeia)  foram  calculados  para  Portugal
continental  e  para  as  regiões  Norte,  Centro,  Lisboa,  Alentejo  e  Algarve.
Resultados:  Em  2013,  perderam-se  95  413  DALY  em  Portugal  por  DIC.  Destes,  88,3%  foram  por
morte prematura.  A  taxa  de  DALY  perdidos  por  1000  habitantes  padronizada  para  a  idade  foi
mais elevada  nos  homens  em  todo  o  país  (8,9  nos  homens;  3,4  nas  mulheres)  e  em  cada  região,
variando  de  7,3  no  Norte  e  Centro  até  11,8  no  Algarve  nos  homens,  e  de  2,6  no  Norte  a  4,6  em
Lisboa nas  mulheres.
Conclusões:  Quase  100  mil  DALY  foram  perdidos  em  Portugal  devido  a  DIC,  essencialmente  por
mortalidade  prematura.  Este  estudo  permite  comparar  a  carga  de  doenc¸a  com  outros  países  e
entre regiões,  salientando-se,  no  entanto,  a  necessidade  de  estudos  de  base  populacional  que
fornec¸am informac¸ão  especíﬁca  de  morbilidade.
© 2017  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Todos  os
direitos reservados.
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schemic  heart  disease  (IHD)  remains  a  leading  cause  of
eath  worldwide.1,2 However,  the  case-fatality  rate  of  acute
yocardial  infarction  has  decreased  markedly,3 resulting
n  a  growing  population  of  survivors  with  disability  due  to
ngina,  recurrent  infarction  or  ischemic  heart  failure.  Fur-
hermore,  the  growth  and  aging  of  populations  means  the
bsolute  number  of  people  living  with  IHD  is  expected  to
ncrease.1
IHD  mortality  in  Portugal  has  decreased  markedly  over
he  last  three  decades,  as  in  most  developed  countries.4
sing  the  IMPACT  IHD  mortality  model,  we  previously  esti-
ated  that  the  proportional  contribution  to  the  decline  in
HD  death  of  the  use  of  treatments  to  reduce  case  fatal-
ty,  compared  to  the  contribution  of  favorable  risk  factor
hanges,  was  larger  than  in  other  countries.5 This  reﬂects
igh-quality  coverage  of  sophisticated  medical  interven-
ions  but  less  effective  primary  prevention,  which  also
ontributes  to  the  prevalence  of  IHD-related  disability  in  the
ortuguese  population.
Disability-adjusted  life  years  (DALYs)  are  a  health  gap
easure  that  combines  both  time  lost  due  to  premature
ortality  and  non-fatal  conditions,  and  are  calculated  as
he  sum  of  years  of  life  lost  (YLLs)  due  to  premature  mortal-
ty  and  years  lost  due  to  disability  (YLDs).6,7 Calculating  the
urden  of  IHD  is  challenging  taking  into  account  its  differ-
nt  clinical  presentations,  including  myocardial  infarction,
ngina  and  heart  failure,  which  raises  methodological  con-
erns  regarding  the  large  amount  of  information  needed  and
B
I
c
ihe  lack  of  registries  in  many  countries,8 including  Portugal.
ccording  to  the  2010  Global  Burden  of  Diseases,  Injuries
nd  Risk  Factors  (GBD)  study,  IHD  is  one  of  the  top  three
auses  of  DALYs  in  Portugal,  along  with  low  back  pain  and
erebrovascular  disease,9 but  without  estimates  of  absolute
ALYs,  YLLs  and  YLDs  numbers,  ranking  positions  alone  do
ot  enable  results  to  be  compared  between  countries,  and
ore  detailed  and  updated  information  are  required.
Previous  reports  on  mortality  time  trends  and  global  esti-
ates  of  the  burden  of  disease  due  to  IHD  in  Portugal  have
onsidered  overall  national  data.  However,  there  is  consider-
ble  variability  within  the  country  in  rates  of  mortality  and
ospital  admissions  of  patients  with  IHD,  possibly  reﬂect-
ng  differences  in  economic  and  social  development  and
rbanization.10 This  variability  can  be  expected  to  impact
ccess  to  health  care  and  the  efﬁciency  of  the  health  sys-
em  in  dealing  with  IHD,  and  if  differences  are  found  in
ALYs  across  regions,  this  may  support  a  readjustment  of
ecommendations  and  allocation  of  healthcare  resources.
Therefore,  our  aim  was  to  estimate  the  burden  of  IHD
n  mainland  Portugal  in  2013  by  calculating  DALYs  and  to
ompare  this  burden  between  ﬁve  regions  of  the  country:
orth,  Central,  Lisbon,  Alentejo  and  Algarve.
ethodsased  on  the  GBD  2010  study,11 we  calculated  the  burden  of
HD,  considering  that  it  may  result  in  death  or  three  general
linical  presentations:  acute  coronary  syndrome  (myocardial
nfarction  and  unstable  angina),  stable  angina,  and  ischemic
Burden  of  ischemic  heart  disease  
Table  1  Sources  of  information  for  each  of  the  parameters
used to  calculate  disability-adjusted  life  years  lost  due  to
ischemic  heart  disease  in  mainland  Portugal,  2013.
Parameter  Information  source
Population  data  INE
Deaths  due  to  IHD  INE
Standard  life  expectancy  GBD  2010
Incidence  of  acute  coronary
syndrome  episodes  in  2013
ACSS
Prevalence  of  stable  angina
episodes
OFRECE  study
Distribution  of  stable  angina  by
severity
AVANCE  registry
Prevalence  of  HF  PRICE  study
Distribution  of  HF  by  etiology  GALICAP  study
Distribution  of  HF  by  severity  GALICAP  study
Disability  weights  GBD  2013
ACSS: Administrac¸ão Central do Sistema de Saúde (Central
Administration of the Health System); GBD: Global Burden of
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the  severity  of  heart  failure,  classiﬁed  according  to  New  YorkDisease Study; HF: heart failure; IHD: ischemic heart disease;
INE: Instituto Nacional de Estatística (Statistics Portugal).
heart  failure.  GBD  studies  prior  to  2010  used  a  3%  discount
rate  and  age  weights  that  placed  the  greatest  emphasis  on
health  outcomes  in  young  adults,  but  in  the  GBD  2010  study,
DALYs  were  simpliﬁed  and  in  the  present  analysis,  no  dis-
count  factors  or  weighting  by  age  were  applied.1
DALYs  were  calculated  for  each  gender  and  age  group
(<40,  40-49,  50-59,  60-69,  70-79,  and  ≥80  years)  and  by
region  of  mainland  Portugal  (Nomenclature  of  Territorial
Units  for  Statistics  [NUTS]  II:  Northern,  Central,  Lisbon,
Alentejo,  Algarve)  that  included  9  918  548  inhabitants  in
2013.12 Similar  procedures  and  data  sources  were  adopted  to
compute  DALYs  for  Portugal  and  for  the  ﬁve  national  regions
considered  for  analysis.  All  sources  of  information  are  sum-
marized  in  Table  1.
Years  of  life  lost  due  to  premature  mortality
YLLs  were  calculated  by  multiplying  the  number  of  deaths
in  each  age  group  by  the  life  expectancy  at  the  age  at  which
death  occurs.13
Data  regarding  the  number  of  deaths  by  IHD  in  each  gen-
der  and  age  group  (ﬁve-year  intervals  until  ≥85  years)  in
Portugal  and  the  ﬁve  regions  in  2013  were  provided  by  Statis-
tics  Portugal.12 All  deaths  with  International  Classiﬁcation  of
Diseases,  Tenth  Revision,  Clinical  Modiﬁcation  (ICD-10-CM)
codes  I20  to  I25  were  considered.14
The  standard  life  expectancy  was  provided  by  the  GBD
2010  study.  It  represents  the  normative  goal  of  survival  and
was  computed  based  on  the  lowest  recorded  death  rates
across  countries  in  2010.  Life  expectancy  at  birth  is  86.02
years,  equal  for  men  and  women.13 Since  only  the  total  num-
ber  of  deaths  by  age  group  was  available,  mean  age  at  death
was  set  to  the  mid-point  of  each  ﬁve-year  age  group,  except
for  the  oldest  group  (assumed  to  be  87.5  years).6 The  total
of  YLLs  for  each  gender  was  obtained  by  summing  the  YLLs
of  all  age  groups.
H
f
m275
ears  lived  with  disability
LDs  due  to  IHD  were  computed  as  the  number  of  cases
ultiplied  by  an  average  disability  weight  for  all  possible
ombinations  of  the  clinical  presentations  (acute  coronary
yndrome,  stable  angina  and  heart  failure),  taken  separately
r  together  (seven  possible  combinations).  For  each  clinical
resentation  we  used  the  most  up-to-date  disability  weights
rovided  by  the  GBD  study.15
Speciﬁc  data  on  the  Portuguese  population  were  used
f  information  was  available  for  the  year  2013.  If  not,  we
referentially  chose  robust  population  studies  carried  out
n  Spain  around  the  year  2013,  with  data  by  gender  and  age
roups,  given  the  similarities  in  patterns  of  cardiovascular
isease  between  the  two  Iberian  countries.16
cute  coronary  syndrome
ata  on  numbers  of  patients  admitted  to  a  hospital  with
yocardial  infarction  or  unstable  angina  were  obtained  from
he  National  Hospital  Discharge  Register,  centrally  held  in
he  Central  Administration  of  the  Health  System  (ACSS).
pisodes  were  selected  in  which  the  main  diagnosis  was
oded  as  410  or  411.1  according  to  the  International  Clas-
iﬁcation  of  Diseases,  Ninth  Revision,  Clinical  Modiﬁcation
ICD-9-CM).  The  duration  of  each  episode  of  acute  coronary
yndrome  was  set  at  28  days,  in  accordance  with  the  GBD
010  study,17 with  the  ﬁrst  two  days  presenting  a  higher  dis-
bility  weight.  This  information  was  used  to  calculate  the
revalence  of  this  clinical  presentation.
table  angina
o  national  studies  reporting  the  prevalence  of  stable  angina
ere  identiﬁed,  therefore  we  used  estimates  from  the
FRECE  study  conducted  between  2010  and  2012,  which
eports  the  prevalence  of  conﬁrmed  angina  by  gender  and
ge  group  in  a  representative  sample  of  the  Spanish  pop-
lation  aged  40  years  or  older.18 Three  levels  of  stable
ngina  were  considered  according  to  severity  (mild,  moder-
te  or  severe),  each  was  assigned  a  speciﬁc  disability  weight
nd  the  proportions  of  angina  cases  were  obtained  from
he  AVANCE  registry.19 The  disability  weight  for  angina  is  the
eighted  average  of  these  speciﬁc  disability  weights.
eart  failure
o  population-based  studies  reporting  the  prevalence  of
eart  failure  in  Portugal  contained  data  collected  more
ecently  than  1998,20 which  we  believe  made  it  impossible  to
rovide  a  credible  scenario  of  the  epidemiology  of  heart  fail-
re  in  2013.  We  therefore  used  data  from  the  Spanish  PRICE
tudy  conducted  between  2004  and  2005.21 Only  ischemic
eart  failure  was  considered,  and  the  proportion  of  heart
ailure  cases  with  ischemic  etiology  was  obtained  from  the
ALICAP  study  conducted  in  a representative  sample  of  Gali-
ia  (northern  Spain)  (36.8%  in  men  and  26.6%  in  women).22
rom  the  same  study,  we  obtained  information  concerningeart  Association  functional  class.23 The  disability  weight
or  ischemic  heart  failure  is  the  weighted  average  of  mild,
oderate  and  severe  speciﬁc  disability  weights.
2 A.  Henriques  et  al.
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alculation  of  average  disability  weights
nd prevalence  of  ischemic  heart  disease
ssuming  that  disability  in  patients  with  multiple  clinical
resentations  increases  but  is  less  than  the  sum  of  indi-
idual  disability  weights,  an  average  disability  weight  for
HD  was  computed  for  each  of  the  seven  possible  combina-
ions  among  all  clinical  manifestations  (only  acute  coronary
yndrome,  only  angina,  only  ischemic  heart  failure,  acute
oronary  syndrome  and  angina,  acute  coronary  syndrome
nd  ischemic  heart  failure,  angina  and  ischemic  heart  fail-
re,  acute  coronary  syndrome  and  angina  and  ischemic
eart  failure),  according  to  the  multiplicative  adjustment
ethod.24
Regarding  the  overlap  of  different  clinical  presentations,
he  overall  prevalence  of  IHD  is  lower  than  the  sum  of  preva-
ences  of  each  diagnosis.  The  probability  of  overlap  was
stimated  assuming  independence  between  diseases24 and
his  proportion  was  subtracted  to  avoid  double  counting  of
ases.  By  multiplying  the  estimated  prevalence  of  each  com-
ination  by  the  resident  population  in  Portugal  in  2013  in
ach  gender  and  age  group,  we  obtained  the  number  of
ases,  which  was  then  multiplied  by  the  average  disability
eight.  To  obtain  the  ﬁnal  YLDs  for  each  gender,  we  summed
he  YLDs  contributed  by  all  seven  combinations.
Age-standardized  DALYs  per  1000  population  were  cal-
ulated  using  the  direct  method  and  were  adjusted  to  the
tandard  European  Population.25
esults
opulation  size  and  number  of  cases  in  mainland  Portugal  in
013  for  each  of  the  clinical  manifestations  used  for  calcu-
ation  of  DALYs  are  presented  in  Table  2.
In  2013,  95  413  DALYs  were  lost  in  mainland  Portugal
ue  to  IHD  (58  689  in  men;  36  724  in  women),  which  cor-
esponds  to  9.6  DALYs  per  1000  population  (12.4  in  men;  7.0
n  women).  The  age-adjusted  DALY  rate  was  6.0  per  1000
opulation  (8.9  in  men;  3.4  in  women).  The  age-adjusted
LL  rate  per  1000  population  was  8.1  and  2.8  in  men  and
omen,  respectively,  which  accounted  for  88%  of  the  dis-
ase  burden  (90%  in  men;  85%  in  women).  The  proportional
ontributions  of  acute  coronary  syndrome,  stable  angina  and
schemic  heart  failure  to  YLDs  are  shown  in  Figure  1, with
ngina  and  heart  failure  being  the  main  contributors,  due  to
heir  chronic  nature.
The  absolute  number  of  DALYs  was  higher  in  men  than
n  women  in  every  age  group  except  those  aged  80  years
r  over.  In  men,  the  highest  burden  of  IHD  was  observed  in
he  70-79  age  group,  accounting  for  15  440  DALYs,  while  in
omen  the  highest  number  of  DALYs  was  observed  in  the
ldest  group  (≥80  years:  17  466)  (Figure  2  and  Table  3).
onsidering  DALYs  per  1000  population,  the  burden  was  high-
st  in  men  and  women  aged  at  least  80  years  (66.8  and  48.4,
espectively)  (Table  3).
Of  the  total  burden  of  IHD  in  men  and  women,  a  higher
roportional  contribution  of  YLLs  was  observed  in  all  age
nd  gender  groups,  with  all  of  the  proportions  being  above
6%.  The  highest  proportional  contribution  of  YLDs  was
bserved  in  women  in  the  40-49,  50-59  and  70-79  age
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Table  3  Years  lived  with  disability,  years  of  life  lost  due  to  premature  mortality  and  disability-adjusted  life  years  in  mainland
Portugal, by  NUTS  II  region,  age  and  gender,  2013.
Men  Women
YLD  YLL  DALYs  YLL/DALYs  DALYs/1000
population
YLD  YLL  DALYs  YLL/DALYs  DALYs/1000
population
Portugal
<40  years 1.10 1227  1228  1.00  0.55  0.55  316  317  1.00  0.14
40-49 years 329  4563  4892  0.93 6.87  242  787  1030  0.76  1.34
50-59 years 1251  9217  10  469 0.88 16.02 563  1912  2475  0.77  3.45
60-69 years  1021  12  366  13  387  0.92  24.70  870  4297  5167  0.83  8.19
70-79 years  2061  13  380  15  440  0.87  40.58  2471  7799  10  270  0.76  20.4
≥80 years  986  12  286  13  272  0.93  66.77  1391  16  075  17  466  0.92  48.4
Total 5649  53  039  58  689  0.90  12.45  5537  31  187  36  724  0.85  7.06
Northern
<40 years  0.48  408  409  100  0.49  0.23  49.1  49.3  1.00  0.06
40-49 years  126  1442  1569  0.92  5.74  94.3  78.9  173  0.46  0.58
50-59 years  483  2254  2738  0.82  10.86  217  454  670  0.68  2.43
60-69 years  361  3485  3846  0.91  20.12  305  1292  1597  0.81  7.22
70-79 years  668  4100  4768  0.86  38.70  810  1911  2721  0.70  16.50
≥80 years  306  2864  3171  0.90  51.30  437.26  3570  4007  0.89  35.27
Total 1946  14  554  16  500  0.88  9.50  1862.92  7355  9218  0.80  4.83
Central
<40 years  0.33  200  200  1.00  0.41  0.13  107  107  1.00  0.22
40-49 years  74.4  483  557  0.87  3.47  54.7  256  310  0.82  1.81
50-59 years  298  1708  2006  0.85  12.93  131  315  446  0.71  2.68
60-69 years  242  2676  2919  0.92  22.80  204  649  853  0.76  5.79
70-79 years  536  2719  3255  0.84  32.91  644  1822  2466  0.74  18.83
≥80 years  278  2996  3274  0.91  58.46  384  3435  3819  0.90  38.31
Total 1429  10  782  12  212  0.88  11.27  1418  6583  8001  0.82  6.68
Lisbon
<40 years  0.06  405  405  1.00  0.63  0.06  107  107  1.00  0.16
40-49 years  89.1  1846  1935  0.95  9.94  663  369  436  0.85  2.06
50-59 years  318  3655  3973  0.92  23.81  150  724  875  0.83  4.56
60-69 years  292  4117  4410  0.93  28.19  259  1665  1925  0.87  10.17
70-79 years  573  4331  4904  0.88  46.17  683  2905  3587  0.81  25.70
≥80 years  245  4508  4752  0.95  95.94  373  6411  6784  0.95  69.84
Total 1517  18  862  20  380  0.93  15.43  1531  1218  13  713  0.89  9.23
Alentejo
<40 years  0.19  102  102  1.00  0.64  0.10  53.0  53.1  1.00  0.35
40-49 years  24.1  541  565  0.96  10.90  16.4  39.4  55.9  0.71  1.08
50-59 years  97.8  907  1005  0.90  19.77  41.1  164  205  0.80  3.96
60-69 years  79.8  1188  1267  0.94  30.07  65.1  411  476  0.86  10.15
70-79 years  187  1625  1811  0.90  52.76  228  896  1124  0.80  24.29
≥80 years  106  1440  1546  0.93  72.54  134  1990  2124  0.94  61.53
Total 494  5803  6298  0.92  17.52  485  3553  4038  0.88  10.52
Algarve
<40 years  0.04  111  111  1.00  1.09  0.03  0.00  0.03  0.00  000
40-49 years  14.6  251  266  0.94  8.51  10.7  44.2  54.9  0.81  164
50-59 years  54.6  692  747  0.93  26.24  23.9  255  278  0.91  919
60-69 years  46.0  900  946  0.95  39.09  36.5  280  316  0.88  1203
70-79 years  96.9  605  702  0.86  39.34  107  265  372  0.71  1712
≥80 years  50.4  478  529  0.90  52.25  62.5  670  732  0.91  4548
Total 263  3037  3300  0.92  15.44  240  1513  1753  0.86  7.67
DALYs: disability-adjusted life years; YLDs: years lived with disability; YLLs: years of life lost due to premature mortality.
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Stable angina Ischemic heart failure
ACS
Figure  1  Proportional  contribution  of  acute  coronary  syn-
drome, stable  angina  and  ischemic  heart  failure  to  years  lived
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Figure  3  Proportion  of  years  of  life  lost  and  years  lived  with
disability  in  total  disability-adjusted  life  years  due  to  ischemic
heart disease  by  age  group  and  gender  in  mainland  Portugal,
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Dith disability  due  to  due  to  ischemic  heart  disease  in  mainland
ortugal,  2013.  ACS:  acute  coronary  syndrome.
roups,  accounting  for  more  than  20%  of  the  disease  burden
Table  3  and  Figure  3).
Table  3  shows  the  number  of  YLDs,  YLLs  and  DALYs  in  the
orthern,  Central,  Lisbon,  Alentejo,  and  Algarve  regions
nd  in  all  of  mainland  Portugal.  Similar  patterns  of  DALYs
nd  their  components  by  age  and  gender  were  observed  in
ainland  Portugal  and  in  all  ﬁve  regions,  with  the  oldest
ge  groups  presenting  the  greater  burden  of  IHD  and  men
osing  more  DALYs  due  to  IHD  than  women.  The  absolute
umber  of  DALYs  was  greatest  in  the  Lisbon  region  (men:
0  380;  women:  13  713)  and  lowest  in  the  Algarve  (men:
300;  women:  1753);  however,  the  highest  crude  DALY  rate
er  1000  population  was  observed  in  the  Alentejo,  with  13.9
ALYs  lost  (17.5  in  men  and  10.5  in  women).  The  lowest
ontribution  of  YLLs  in  men  was  found  in  the  Northern
egion,  accounting  for  82%  of  the  DALYs  in  men  aged  50-59
ears.  Concomitantly,  the  region  in  which  the  impact  of  YLLs
as  lowest  for  women  was  also  the  Northern,  which  was
he  only  region  with  proportions  lower  than  70%  (Table  3).
Figure  4  depicts  the  age-standardized  DALY  rate  per
000  population  in  the  Northern,  Central,  Lisbon,  Alentejo
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igure  2  Disability-adjusted  life  years  due  to  ischemic  heart
isease  by  age  group  and  gender  in  mainland  Portugal,  2013.
ALYs: disability-adjusted  life  years;  M:  men;  W:  women.
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w013.  M:  men;  W:  women;  YLD:  years  lived  with  disability;  YLL:
ears of  life  lost  due  to  premature  mortality.
nd  Algarve  regions.  DALY  rates  were  higher  in  men  than
n  women  within  each  region  across  the  entire  country:
n  men,  they  ranged  from  7.3  in  the  Northern  and  Central
egions  to  11.8  in  the  Algarve;  in  women  they  ranged  from
.6  in  the  Northern  region  and  4.6  in  Lisbon.  A  similar
attern  was  observed  for  men  and  women  across  the
ountry,  with  the  Northern  and  Central  regions  presenting
 smaller  number  of  DALYs  lost  due  to  IHD  compared  to  the
ther  regions  (Figure  4).
iscussion
ur  results  describe  the  burden  of  IHD  in  Portugal  through
alculation  of  DALYs,  providing  information  on  mortality
nd  disability  and  pulling  together  information  on  acute
pisodes  and  chronic  expressions  of  the  disease.  In  2013,
early  100  000  DALYs  were  lost  due  to  IHD.  Individuals  aged
ver  70  years  presented  the  highest  number  of  DALYs,  and
he  burden  was  greater  in  men  than  in  women.  YLLs  were
he  major  contributors  to  DALYs  lost  in  both  sexes  and  in
lmost  all  age  groups.  Comparing  the  different  regions  of
ortugal,  despite  some  regional  disparities,  similar  patterns
f  DALYs  and  their  components  by  age  and  gender  were
ound  in  men  and  women,  with  men  presenting  a  higher
ge-standardized  DALY  rate  per  1000  population  in  all
egions  considered  in  the  analysis.
The  age-standardized  value  of  6.0  DALYs  per  1000  popu-
ation  found  for  Portugal  in  2013  is  close  to  the  most  recent
stimates  for  Spain,  in  2008  (8.6).26 Considering  data  from
he  GBD  2010  study,  the  age-standardized  rate  of  DALYs  lost
n  Western  Europe  due  to  IHD  was  11.6  per  1000  popula-
ion,  and  thus  our  estimates  are  lower  compared  to  the  most
ecent  European  results.27
Similarities  between  the  Iberian  countries  may  to  some
xtent  be  artiﬁcial  due  to  the  use  of  the  same  data  sources,
articularly  for  angina  and  heart  failure;  however,  since  the
urden  of  IHD  is  mainly  attributable  to  mortality,  for  which
e  used  country-speciﬁc  data,  we  believe  that  this  cannot
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Figure  4  Age-standardized  (Standard  European  Population;  direct  method)  disability-adjusted  life  years  due  to  ischemic  heart
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totally  explain  the  similarities  between  Portugal  and  Spain.
For  stable  angina  and  heart  failure,  we  used  information
from  Spain.  Although  this  is  a  limitation,  there  are  similar-
ities  between  the  two  countries  in  location,  socioeconomic
and  health  characteristics.28 No  study  on  angina  prevalence
using  a  Portuguese  population-based  sample  was  found,
but  the  OFRECE  study  provided  an  estimate  of  prevalences
of  conﬁrmed  angina  in  a  representative  sample  of  Spanish
adults.18 Even  within  Europe,  considerable  variability  is
observed,  with  countries  from  the  north  of  Europe  present-
ing  higher  prevalences  of  angina  at  least  at  older  ages,29
and  so  when  national  data  are  not  available,  care  needs  to
be  taken  to  choose  estimates  from  a  country  that  resembles
Portugal  at  least  from  a  health  perspective.  Concerning
heart  failure,  the  EPICA  study  provides  national  data  on
prevalence  and  severity,  based  on  subjects  attending
primary  health  care  centers  in  the  community;  however,  it
was  conducted  in  the  1990s.20 The  PRICE  study,  although
still  well  before  2013,  is  more  recent  than  the  EPICA
study,  to  which  it  bears  considerable  sociodemographic  and
methodological  similarities.  Moreover,  the  Spanish  study
provides  exact  prevalence  estimates  by  age  and  gender,
whereas  the  Portuguese  study  only  displays  them  in  a  chart,
requiring  an  approximate  reading.  We  therefore  consid-
ered  that  the  more  recent  Spanish  data  would  be  more
appropriate.
The  use  of  data  from  the  National  Hospital  Discharge
Register  for  the  number  of  patients  with  acute  coronary
a
p
p
ﬁd  Portugal,  2013.  DALYs:  disability-adjusted  life  years.
yndrome  may  have  led  to  an  underestimate  of  the  asso-
iated  YLDs,  not  only  because  it  includes  only  inpatients  at
ublic  hospitals  but  also  because  cases  that  were  never  hos-
italized,  particularly  those  that  were  asymptomatic  or  with
typical  presentation,  may  have  not  been  considered.  How-
ver,  the  magnitude  of  this  error  is  expected  to  be  low  and
ithout  a  signiﬁcant  impact  in  terms  of  YLDs.  Considering
he  proportion  of  DALYs  attributed  to  YLLs,  the  results  in
he  present  study  are  in  accordance  with  the  89%  found  in
estern  Europe27 and  lower  than  the  96%  found  in  the  Span-
sh  population.26 In  2003-2005,  estimates  for  the  Northern
egion  of  Portugal  attributed  75%  of  the  burden  of  IHD  to
LLs,30 which  is  lower  than  the  value  estimated  in  this  study.
Differences  between  countries  may  be  partially
xplained  by  the  use  of  different  data  sources  and
ifferent  discount  rates  and  age  weighting  (2004  GBD
ethods).  Nevertheless,  for  computation  of  DALYs  in  this
tudy,  we  used  the  most  recent  GBD  guidelines,  which
re  not  age-weighted  or  discounted  over  time,  in  order  to
acilitate  comparisons  with  recent  studies,  and  we  consider
hat  this  approach  should  be  used  from  now  on.
At  the  same  time,  the  lack  of  up-to-date  data  regarding
he  prevalence  of  stable  angina  and  heart  failure  is  clearly
 limitation,  since  the  absence  of  national  data  means  the
nalysis  may  not  reﬂect  their  prevalence  in  the  Portuguese
opulation.  The  fact  that  the  severity  of  these  two  clinical
resentations  by  region,  gender  and  age  group  is  not  speci-
ed  is  also  a  limitation;  it  is  likely  that  this  lack  of  precision
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ill  mainly  affect  smaller  regions  and  younger  populations,
hich  might  result  in  our  results  underestimating  the  differ-
nces  between  strata.
Considering  the  ﬁve  different  regions  of  Portugal  in  this
nalysis,  no  substantial  differences  were  found  in  the  pat-
erns  of  DALYs  between  men  and  women,  although  the
ge-standardized  DALY  rate  per  1000  population  was  lower
n  the  Northern  and  Central  regions  in  both  sexes.  Although
verall  living  standards  have  improved,  there  are  disparities
n  some  health  indicators  (e.g.  cancer  mortality  rates,  infant
ortality,  and  number  of  physicians  and  nurses  per  100  000
opulation),  with  the  Northern  region  always  appearing
mong  the  best  positions.31 There  is  no  systematic  informa-
ion  regarding  trends  in  risk  factors  by  Portuguese  regions,
ut  the  AMALIA  study32 conducted  in  2006-2007  showed  that
he  Northern  region  has  a  lower  prevalence  of  hypercholes-
erolemia,  hypertension,  diabetes  and  obesity  compared  to
ther  national  regions.  If  the  risk  factors  for  IHD  are  lower
n  this  region,  a  lower  burden  of  IHD  can  also  be  expected.
oreover,  a  similar  pattern  can  be  found  in  crude  mortal-
ty  rates  due  to  IHD  in  Portugal,  by  gender  and  region,  with
en  presenting  higher  rates  in  each  region  and  the  North-
rn  and  Central  regions  presenting  a  more  favorable  scenario
ompared  to  Lisbon,  the  Alentejo  and  the  Algarve.33
In  this  study,  YLLs  accounted  for  a  higher  contribution  to
he  disease  burden  in  men  than  in  women,  which  is  in  agree-
ent  with  higher  adjusted  mortality  and  risks  attributed
o  IHD  in  men  observed  in  other  countries.16 Lower  IHD
ortality  among  women  is  most  likely  explained  by  their
etter  risk  factor  proﬁle,  even  though  there  is  evidence
f  higher  in-hospital  mortality  after  a  cardiovascular  event
nd  lower  access  to  evidence-based  secondary  prevention  in
omen  compared  to  men.34 A  recent  study  showed  a  trend
owards  smaller  gender  differences  in  discharge  medica-
ions  of  patients  admitted  with  acute  coronary  syndromes
n  Portugal,  after  adjusting  for  the  potential  confound-
ng  effects  of  age,  comorbidities  and  contraindications,35
hich  is  also  a  possible  explanation  for  the  lower  burden
ue  to  YLLs  found  among  women.  Moreover,  women  tend
o  adhere  more  strictly  to  their  doctor’s  recommendations
nd  to  adopt  behaviors  that  will  reduce  the  risk  of  car-
iovascular  disease,36 which  may  contribute  to  the  results
ound.
onclusions
he  burden  of  IHD  has  a  considerable  impact  on  the  health
f  Portuguese  adults,  particularly  in  the  oldest  age  groups
nd  mainly  in  terms  of  mortality.  A  regional  approach  to
HD  prevention  is  needed  in  order  to  provide  cost-effective
nterventions  for  treatment  and  prevention  of  IHD.
Our  results  can  be  used  as  a  basis  to  study  the  burden
f  IHD  in  Portugal,  using  the  most  recent  GBD  guidelines.
alculation  of  DALYs  should  be  conducted  periodically  in
rder  to  analyze  changes  in  this  burden  over  time.  This
tudy’s  systematic  and  transparent  methodology  enables
ccurate  comparisons  with  other  countries  and  between
egions  within  the  country;  however,  it  highlights  the  need
or  population-based  studies  to  obtain  speciﬁc  data  on  mor-
idity  and  to  provide  accurate  national  data  by  gender,  age
nd  region.A.  Henriques  et  al.
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